HISTONDEMETHYLASEINHIBITOREN

Patent europeic · EP3445752 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3445752
Numer da la dumonda
EP17786401
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
17-04-2017
Publitgà
27-02-2019
Concedì
12-01-2022
Stritgà
23-11-2022
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 401/14 (2006.01)
A61P 35/00 (2006.01)
A61K 31/4439 (2006.01)
Prioritad
US 201662324813 P 19.04.2016
Dumonda PCT
PCT/US2017/027889 17.04.2017
Publicaziun PCT
WO2017/184491 26.10.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-11-2022

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.11.2022

  2. 23-11-2022

    Midada

    Published in Swissreg on 23.11.2022

  3. 12-01-2022

    Concedì

    Published in Swissreg on 12.01.2022

Partidas

Possessur

Celgene Quanticel Research, Inc.

9393 Towne Centre Drive, Suite 110, San Diego, CA 92121, US

Inventur

STAFFORD, Jeffrey A.

San Diego, California 92130, US

VEAL, James M.

Apex, North Carolina 27502, US

NIE, Zhe

San Diego, California 92127, US

WALLACE, Michael B.

San Diego, California 92117, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.